Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Bernhard G. Zimmermann"'
Autor:
Justin P. Rosenheck, DO, David J. Ross, MD, Mena Botros, MD, Alexander Wong, MD, Jonathan Sternberg, PhD, Yen-An Chen, MS, Nathan Liang, BA, Amy Baer, MS, Ebad Ahmed, PhD, Ryan Swenerton, PhD, Bernhard G. Zimmermann, PhD, Gordon Fehringer, PhD, Zachary P. Demko, PhD, Michael Olymbios, MD, Paul R. Billings, MD, PhD, Brian C. Keller, MD, PhD
Publikováno v:
Transplantation Direct, Vol 8, Iss 4, p e1317 (2022)
Background. Lung transplant patients are vulnerable to various forms of allograft injury, whether from acute rejection (AR) (encompassing acute cellular rejection [ACR] and antibody-mediated rejection [AMR]), chronic lung allograft dysfunction (CLAD)
Externí odkaz:
https://doaj.org/article/9edea27d61424d5caf9b33424f5d3cb2
Autor:
Tenna V. Henriksen, Thomas Reinert, Emil Christensen, Himanshu Sethi, Karin Birkenkamp‐Demtröder, Mikail Gögenur, Ismail Gögenur, Bernhard G. Zimmermann, The IMPROVE Study Group, Lars Dyrskjøt, Claus L. Andersen
Publikováno v:
Molecular Oncology, Vol 14, Iss 8, Pp 1670-1679 (2020)
Detection of circulating tumor DNA (ctDNA) post‐treatment is an emerging marker of residual disease. ctDNA constitutes only a minor fraction of the cell‐free DNA (cfDNA) circulating in cancer patients, complicating ctDNA detection. This is exacer
Externí odkaz:
https://doaj.org/article/1a0853f72d514abf8dadcf4dce6648a3
Autor:
Philip F, Halloran, Jeff, Reeve, Katelynn S, Madill-Thomsen, Navchetan, Kaur, Ebad, Ahmed, Carlos, Cantos, Nour, Al Haj Baddar, Zachary, Demko, Nathan, Liang, Ryan K, Swenerton, Bernhard G, Zimmermann, Paul, Van Hummelen, Adam, Prewett, Matthew, Rabinowitz, Hossein, Tabriziani, Phil, Gauthier, Paul, Billings, Sindhura, Bobba
Publikováno v:
Transplantation. 106(12)
Donor-derived cell-free DNA (dd-cfDNA) fraction and quantity have both been shown to be associated with allograft rejection. The present study compared the relative predictive power of each of these variables to the combination of the two, and develo
Autor:
Justin P. Rosenheck, David J. Ross, Mena Botros, Alexander Wong, Jonathan Sternberg, Yen-An Chen, Nathan Liang, Amy Baer, Ebad Ahmed, Ryan K. Swenerton, Bernhard G. Zimmermann, Gordon Fehringer, Zachary P. Demko, Michael Olymbios, Cesar Escrig, Paul R. Billings, Brian C. Keller
Publikováno v:
Transplantation. 106:S496-S497
Autor:
Pedro Ventura-Aguiar, Maria Jose Ramirez-Bajo, Jordi Rovira, Elisenda Bañón-Maneus, Natalia Hierro, Marta Lazo, Miriam Cuatrecasas, M.A. Garcia-Criado, Nathan Liang, Ryan K. Swenerton, Federic Cofan, David Cucchiari, Nuria Esforzado, Enrique Montagud-Marrahi, Federic Oppenheimer, Gaston Piñeiro, Ignacio Revuelta, Vicens Torregrosa, Ebad Ahmed, Karina Soboleva, Navchetan Kaur, Bernhard G. Zimmermann, Nour Al Haj Baddar, Zachary P. Demko, Cesar Escrig, Hossein Tabriziani, Philippe Gauthier, Paul R. Billings, Antonio J. Amor, Joana Ferrer, Josep M. Campistol, Fritz Diekmann
Publikováno v:
Transplantation. 106(8)
Pancreas graft status in simultaneous pancreas-kidney transplant (SPKTx) is currently assessed by nonspecific biochemical markers, typically amylase or lipase. Identifying a noninvasive biomarker with good sensitivity in detecting early pancreas graf
Autor:
Justin P. Rosenheck, David J. Ross, Mena Botros, Alexander Wong, Jonathan Sternberg, Yen-An Chen, Nathan Liang, Amy Baer, Ebad Ahmed, Ryan Swenerton, Bernhard G. Zimmermann, Gordon Fehringer, Zachary P. Demko, Michael Olymbios, Paul R. Billings, Brian C. Keller
Publikováno v:
Transplantation direct. 8(4)
Lung transplant patients are vulnerable to various forms of allograft injury, whether from acute rejection (AR) (encompassing acute cellular rejection [ACR] and antibody-mediated rejection [AMR]), chronic lung allograft dysfunction (CLAD), or infecti
Autor:
Philip F Halloran, Jeff Reeve, Katelynn S Madill-Thomsen, Navchetan Kaur, Ebad Ahmed, Nour Al Haj Baddar, Zachary Demko, Nathan Liang, Ryan K Swenerton, Bernhard G Zimmermann, Paul Van Hummelen, Adam Prewett, Hossein Tabriziani, Philippe Gauthier, Cesar Escrig, Paul R Billings
Publikováno v:
Transplantation. 106:S496-S496
Publikováno v:
PLoS ONE, Vol 6, Iss 10, p e25202 (2011)
ObjectiveCell-free fetal DNA is a source of fetal genetic material that can be used for non-invasive prenatal diagnosis. Usually constituting less than 10% of the total cell free DNA in maternal plasma, the majority is maternal in origin. Optimizing
Externí odkaz:
https://doaj.org/article/de52d2f54a3f4c2185a430ce753d4f4c
Autor:
Bernhard G. Zimmermann
Publikováno v:
LaboratoriumsMedizin. 31:165-170
Zusammenfassung Seit Jahrzehnten gab es Bestrebungen Informationen aus dem Blut der werdenden Mutter zur nicht-invasiven Schwangerschaftsdiagnostik zu nutzen. Das Ziel waren in den Neunzigerjahren fetale Zellen und deren Anreicherung; die hochgesteck
Publikováno v:
Methods in molecular biology (Clifton, N.J.). 444
The analysis of cell-free fetal DNA in the circulation of the pregnant woman plays the pivotal role in noninvasive prenatal research. Here, we describe an improved method for the quantification of male DNA, which is a valuable research tool for the q